JPH06343468A - Enzyme composition - Google Patents

Enzyme composition

Info

Publication number
JPH06343468A
JPH06343468A JP5158196A JP15819693A JPH06343468A JP H06343468 A JPH06343468 A JP H06343468A JP 5158196 A JP5158196 A JP 5158196A JP 15819693 A JP15819693 A JP 15819693A JP H06343468 A JPH06343468 A JP H06343468A
Authority
JP
Japan
Prior art keywords
enzyme
restriction enzyme
enzyme composition
calcium
buffer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5158196A
Other languages
Japanese (ja)
Other versions
JP3184009B2 (en
Inventor
Haruhisa Sawaragi
治久 椹木
Sadaji Yokoyama
定治 横山
Yoshiko Nomura
佳子 野村
Fusao Kimizuka
房夫 君塚
Kazuo Nakajima
和男 中島
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takara Shuzo Co Ltd
Original Assignee
Takara Shuzo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takara Shuzo Co Ltd filed Critical Takara Shuzo Co Ltd
Priority to JP15819693A priority Critical patent/JP3184009B2/en
Publication of JPH06343468A publication Critical patent/JPH06343468A/en
Application granted granted Critical
Publication of JP3184009B2 publication Critical patent/JP3184009B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Enzymes And Modification Thereof (AREA)

Abstract

PURPOSE:To obtain a restriction enzyme composition containing a stabilizing agent useful for the long-term stabilization of restriction enzyme. CONSTITUTION:The enzyme composition is a stabilized restriction enzyme composition containing a calcium salt. The restriction enzyme is e.g. SfiI and SdiI and the calcium salt is e.g. calcium chloride, calcium nitrate and calcium acetate.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、安定化された制限酵素
組成物に関する。
FIELD OF THE INVENTION This invention relates to stabilized restriction enzyme compositions.

【0002】[0002]

【従来の技術】制限酵素はDNA中のある特定の塩基配
列を認識し切断することができるエンド型ヌクレアーゼ
であり、遺伝子工学の分野において不可欠の有用な酵素
である。しかしながら、制限酵素には不安定なものが多
く、その安定化のための手段が検討されている。例え
ば、制限酵素SfiIはストレプトミセス フィムブラ
イアタス(Streptomyces fimbriatus)により生産される
制限酵素であり、二本鎖DNAの5′−GGCCNNN
N↓NGGCC−3′(Gはグアノシン、Cはシチジ
ン、Nは任意のヌクレオシドを表す)なる塩基配列(配
列表の配列番号1で表される)を認識し矢印の部位で切
断する数少ない8塩基認識の制限酵素の1つであり〔ヌ
クレイック アシッズ リサーチ(Nucleic Acids Rese
arch) 、第12巻、第4507〜4516頁(198
4)〕、その製造方法についてはメソッズ イン エン
ザイロモジー(Methods in Enzymology)、第155巻、
第15〜21頁(1987)に記載されている。このS
fiIは大変不安定な酵素でありその濃度に関わらず、
精製操作時、希釈時、−20℃保存中等にその活性は相
当低下する。したがって、SfiIの濃度調整や長時間
の一定品質の維持は大変困難である。特開平4−239
87号公報には、SfiIの安定化剤として塩化マグネ
シウムを使用することにより安定化されたSfiI組成
物が得られる旨が記載されている。
2. Description of the Related Art A restriction enzyme is an endonuclease capable of recognizing and cleaving a specific base sequence in DNA and is an essential and useful enzyme in the field of genetic engineering. However, many restriction enzymes are unstable, and means for stabilizing them have been studied. For example, the restriction enzyme SfiI is a restriction enzyme produced by Streptomyces fimbriatus, which is a double-stranded DNA 5'-GGCCNNN.
Narrow NGGCC-3 '(G is guanosine, C is cytidine, N is an arbitrary nucleoside) A small number of 8 bases that recognizes the base sequence (represented by SEQ ID NO: 1 in the sequence listing) and cleaves at the position of the arrow It is one of the restriction enzymes for recognition [Nucleic Acids Research (Nucleic Acids Rese
arch), vol. 12, p. 4507-4516 (198)
4)], for its manufacturing method, Methods in Enzymology, Volume 155,
15 to 21 (1987). This S
fiI is a very unstable enzyme, regardless of its concentration,
During the purification operation, dilution, storage at -20 ° C, etc., the activity is considerably reduced. Therefore, it is very difficult to adjust the concentration of SfiI and maintain a constant quality for a long time. JP-A-4-239
No. 87 describes that a stabilized SfiI composition can be obtained by using magnesium chloride as a stabilizer for SfiI.

【0003】[0003]

【発明が解決しようとする課題】しかしながら、Sfi
Iの安定化剤に塩化マグネシウムを加えても長期間のう
ちにはやはり失活は進行する。したがって、強力な制限
酵素の安定化剤の開発が望まれていた。本発明の目的
は、制限酵素の長期安定化に有用な安定化剤を含有する
制限酵素組成物を提供することにある。
[Problems to be Solved by the Invention] However, Sfi
Even if magnesium chloride is added to the stabilizer of I, deactivation still progresses over a long period of time. Therefore, it has been desired to develop a strong stabilizer for restriction enzymes. An object of the present invention is to provide a restriction enzyme composition containing a stabilizer useful for long-term stabilization of restriction enzymes.

【0004】[0004]

【課題を解決するための手段】本発明を概説すれば、本
発明は安定化された制限酵素の組成物に関し、カルシウ
ム塩を含有することを特徴とする。
SUMMARY OF THE INVENTION In general terms, the present invention relates to a composition of stabilized restriction enzymes, characterized in that it contains a calcium salt.

【0005】本発明者らは鋭意研究した結果、安定化剤
としてカルシウム塩を用いることで制限酵素の長期安定
化された組成物が得られることを見いだし、本発明を完
成した。
As a result of intensive studies, the inventors of the present invention found that a long-term stabilized composition of a restriction enzyme can be obtained by using a calcium salt as a stabilizer, and completed the present invention.

【0006】以下、本発明を詳細に説明する。本発明に
使用する制限酵素としては、カルシウム塩で安定化され
る制限酵素をすべて含むが、例えば前述のSfiIが代
表的である。その他、比較的不安定な制限酵素、例え
ば、ClaI、EcoO65I等についてもカルシウム
塩の効果がある。
The present invention will be described in detail below. The restriction enzymes used in the present invention include all restriction enzymes that are stabilized with calcium salts, and the above-mentioned SfiI is typical. In addition, calcium salts have an effect on relatively unstable restriction enzymes such as ClaI and EcoO65I.

【0007】また、SfiIと同じ認識配列と切断部位
を有する制限酵素としてストレプトミセス ディアスタ
ティカス(Streptomyces diastaticus) が生産する制限
酵素が挙げられる。該制限酵素は本発明者らが見出した
新規の酵素があり、本発明者らはSdiIと命名した。
SdiIとSfiIと若干異なる基質特異性をもってい
る。すなわち、SfiIはHaeIII メチラーゼでメチ
ル化された二本鎖DNAを切断する〔ヌクレイック ア
シッズ リサーチ、第19巻、増補、第2045〜20
71頁(1991)〕。言い替えれば、下記式(化
2):
As a restriction enzyme having the same recognition sequence and cleavage site as SfiI, a restriction enzyme produced by Streptomyces diastaticus can be mentioned. The restriction enzyme is a novel enzyme found by the present inventors, and the present inventors named it SdiI.
It has a slightly different substrate specificity from SdiI and SfiI. That is, SfiI cleaves double-stranded DNA methylated with HaeIII methylase [Nucleic Acids Research, Vol. 19, Supplement, 2045-20].
71 (1991)]. In other words, the following formula (Formula 2):

【0008】[0008]

【化2】 [Chemical 2]

【0009】(式中、Gはグアノシン、Cはシチジン、
5mCは5−メチルシチジン、Nは任意のヌクレオシドを
表す)で表される塩基配列(配列表の配列番号2で表さ
れる)をも認識し、矢印の部位で切断する。これに対
し、SdiIは該二本鎖DNAを切断する活性は著しく
低い。
(Wherein G is guanosine, C is cytidine,
5m C also recognizes a base sequence represented by 5-methylcytidine and N represents an arbitrary nucleoside (represented by SEQ ID NO: 2 in the sequence listing), and cleaves at the position of the arrow. On the other hand, SdiI has a remarkably low activity of cleaving the double-stranded DNA.

【0010】SdiIの他の理化学的性質は以下の通り
である。 (1)反応至適温度 約50℃ (2)至適塩濃度 塩化ナトリウム、塩化カリウムの場合50〜120mM (3)至適pH 8.0付近
Other physicochemical properties of SdiI are as follows. (1) Optimum reaction temperature about 50 ° C (2) Optimum salt concentration 50 to 120 mM in the case of sodium chloride and potassium chloride (3) Optimum pH around 8.0

【0011】なお、本発明に使用する制限酵素は制限酵
素生産菌の培養物から採取してもよく、制限酵素の遺伝
子をクローニングして他の生物に導入した形質転換体に
よって生産してもよい。本発明の酵素組成物の形状とし
ては溶液状でもよく凍結乾燥物でもよい。
The restriction enzyme used in the present invention may be collected from a culture of a restriction enzyme-producing bacterium, or may be produced by a transformant in which the gene for the restriction enzyme is cloned and introduced into another organism. . The enzyme composition of the present invention may be in the form of a solution or a freeze-dried product.

【0012】本発明に使用するカルシウム塩としては水
溶性のものであればよく、例えば塩化カルシウム、酢酸
カルシウム、硝酸カルシウムが挙げられる。カルシウム
塩の濃度は塩の種類等によって適宜選択すればよい。
The calcium salt used in the present invention may be any water-soluble one, and examples thereof include calcium chloride, calcium acetate and calcium nitrate. The concentration of calcium salt may be appropriately selected depending on the type of salt and the like.

【0013】本発明の酵素組成物には安定化剤として塩
化マグネシウム等のマグネシウム塩が含まれていてもよ
い。マグネシウム塩を加えることにより安定化の相乗効
果を期待できる。本発明の酵素組成物にはグリセロール
が含まれていてもよい。グリセロールの濃度としては、
−20℃で保存中に凍結しない範囲であればよく、通常
40〜60%(v/v)、好ましくは50%である。本
発明の酵素組成物には緩衝剤が含まれていてもよい。緩
衝剤としては通常の物が使用され、該酵素組成物のpH
を7〜8とするものが好ましい。例えばトリス−塩酸緩
衝液、トリス−リン酸緩衝液等である。本発明の酵素組
成物には必要により他の成分が含まれていてもよい。他
の成分としては塩化ナトリウム、塩化カリウム、エチレ
ンジアミン四酢酸(EDTA)、ジチオスレイトール
(DTT)、牛血清アルブミン(BSA)、トリトン
(Triton) X−100等が挙げられる。
The enzyme composition of the present invention may contain a magnesium salt such as magnesium chloride as a stabilizer. A synergistic effect of stabilization can be expected by adding magnesium salt. Glycerol may be contained in the enzyme composition of the present invention. As for the concentration of glycerol,
It may be in a range that does not freeze at −20 ° C. during storage, and is usually 40 to 60% (v / v), preferably 50%. The enzyme composition of the present invention may contain a buffer. An ordinary buffer is used as the buffer, and the pH of the enzyme composition is
Is preferably 7 to 8. For example, Tris-hydrochloric acid buffer solution, Tris-phosphate buffer solution and the like. If necessary, the enzyme composition of the present invention may contain other components. Other components include sodium chloride, potassium chloride, ethylenediaminetetraacetic acid (EDTA), dithiothreitol (DTT), bovine serum albumin (BSA), Triton X-100 and the like.

【0014】以下に参考例として、制限酵素の1例を示
す。 参考例1 30リットル容のジャーファーメンターに下記表1に示
す培地20リットルを仕込み、常法により培地を滅菌し
た。
As a reference example, one example of restriction enzyme will be shown below. Reference Example 1 A 30-liter jar fermenter was charged with 20 liters of the medium shown in Table 1 below, and the medium was sterilized by a conventional method.

【0015】[0015]

【表1】 表 1 グリセロール 17.5g 酵母エキス 3.5g ポリペプトン 3.5g 肉エキス 3.5g 塩化ナトリウム 2.0g リン酸水素二カリウム 1.0g 硫酸マグネシウム 0.5g 脱イオン水 1リットル (pH7.2〜7.4)Table 1 Glycerol 17.5 g Yeast extract 3.5 g Polypeptone 3.5 g Meat extract 3.5 g Sodium chloride 2.0 g Dipotassium hydrogen phosphate 1.0 g Magnesium sulfate 0.5 g Deionized water 1 liter (pH 7. 2-7.4)

【0016】表1と同じ培地で30℃で48時間振とう
培養したストレプトミセス ディアスタティカスの種培
養液200mlを上記ジャーファーメンターに移植し、
通気量2/3vvm、かくはん回転数250rpm、培
養温度30℃で24時間培養を行った。培養終了後、冷
却遠心機を用いて集菌し、培養液20リットルから約1
220gの湿菌体が得られた。次に、200gの湿菌体
を400mlの緩衝液A〔10mM トリス−塩酸pH
7.5、10mM 2−メルカプトエタノール、20m
M CaCl2 、5%(v/v)グリセロール〕に懸濁
し、超音波破砕後、得られた抽出液に11mlの8%
(v/v)ポリエチレンイミン溶液を添加し、4℃で1
時間放置後、10000×gで10分間遠心分離を行
い、上清を回収した。得られた上清を0.3M NaC
lを含む緩衝液Aで一晩透析を行った。次に、透析内液
をあらかじめ0.3M NaClを含む緩衝液Aで平衡
化させておいたヘパリン−セファロース(ファルマシア
社)50mlのカラムに吸着させ、0.3M NaCl
を含む緩衝液で洗浄後、0.3〜1.0M NaClの
直線濃度勾配をもつ緩衝液で溶出させた。得られた活性
画分を集め、緩衝液Aに対して4時間透析を行い、透析
内液をあらかじめ緩衝液Aで平衡化したアミノヘキシル
−セファロース(ファルマシア社)10mlのカラムに
吸着させた。緩衝液Aでカラムを洗浄後、0〜0.8M
NaClの直線濃度勾配をもつ緩衝液Aで溶出させ
た。次に、得られた活性画分を合わせ、0.15M N
aClを含む緩衝液Aに対して4時間透析を行い、透析
内液をあらかじめ0.15M NaClを含む緩衝液A
で平衡化したヘパリン−セファロース5mlのカラムに
吸着させた。0.15M NaClを含む緩衝液Aでカ
ラムを十分洗浄したのち、0.15〜1.0M NaC
lの直線濃度勾配をもつ緩衝液Aで溶出し、制限酵素S
diIの酵素標品を得た。この酵素標品には非特異的な
DNA分解酵素、及びホスファターゼはきょう雑してい
なかった。以上述べた方法により、200gの湿菌体か
ら20000単位の活性が得られた。
200 ml of a Streptomyces diasterticus seed culture solution, which had been shake-cultured at 30 ° C. for 48 hours in the same medium as in Table 1, was transplanted to the jar fermenter,
The culture was performed at an aeration rate of 2/3 vvm, a stirring rotation speed of 250 rpm, and a culture temperature of 30 ° C. for 24 hours. After completion of the culturing, the cells were collected using a cooling centrifuge, and approximately 20
220 g of wet cells were obtained. Next, 200 g of wet bacterial cells was added to 400 ml of buffer A [10 mM Tris-HCl pH.
7.5, 10 mM 2-mercaptoethanol, 20 m
M CaCl 2 , 5% (v / v) glycerol] and ultrasonically disrupted. 11 ml of 8% was added to the resulting extract.
(V / v) Add polyethyleneimine solution and add 1 at 4 ° C
After being left for an hour, centrifugation was performed at 10,000 × g for 10 minutes, and the supernatant was collected. The obtained supernatant is treated with 0.3M NaCl
Dialysis was carried out against Buffer A containing 1 overnight. Next, the dialyzed solution was adsorbed on a column of 50 ml of heparin-Sepharose (Pharmacia), which had been equilibrated with the buffer solution A containing 0.3 M NaCl in advance, to obtain 0.3 M NaCl.
After washing with a buffer solution containing the above, the elution was performed with a buffer solution having a linear concentration gradient of 0.3 to 1.0 M NaCl. The obtained active fractions were collected, dialyzed against buffer A for 4 hours, and the dialyzed solution was adsorbed on a 10 ml column of aminohexyl-sepharose (Pharmacia) previously equilibrated with buffer A. After washing the column with buffer A, 0-0.8M
Elution was performed with buffer A having a linear concentration gradient of NaCl. Next, the obtained active fractions were combined to obtain 0.15M N
The solution A containing aCl was dialyzed for 4 hours, and the dialysis solution was preliminarily adjusted to a solution A containing 0.15M NaCl.
It was adsorbed onto a column of 5 ml of heparin-sepharose equilibrated with. After thoroughly washing the column with buffer A containing 0.15 M NaCl, 0.15-1.0 M NaCl was added.
Elution with buffer A having a linear concentration gradient of 1
An enzyme preparation of diI was obtained. This enzyme preparation was not contaminated with non-specific DNA degrading enzyme and phosphatase. According to the method described above, 20,000 units of activity were obtained from 200 g of wet cells.

【0017】活性の測定は、活性測定用緩衝液(10m
M トリス−塩酸 pH7.5、10mM MgC
2 、50mM NaCl、1mM DTT)50μl
中でアデノウイルスDNAを基質として50℃にて酵素
反応を行い、反応後アガロースゲル電気泳動を行い基質
の分解の程度を検出して行った。50℃で1時間に1μ
gの基質を完全に切断する酵素活性を1単位とした。
The activity is measured by a buffer solution for activity measurement (10 m
M Tris-hydrochloric acid pH 7.5, 10 mM MgC
l 2 , 50 mM NaCl, 1 mM DTT) 50 μl
The enzyme reaction was carried out at 50 ° C. using adenovirus DNA as a substrate, and after the reaction, agarose gel electrophoresis was performed to detect the degree of decomposition of the substrate. 1μ per hour at 50 ° C
One unit was defined as the enzyme activity that completely cleaved g substrate.

【0018】[0018]

【実施例】以下、実施例をもって本発明を更に詳細に説
明するが、本発明はこれらに限定されるものではない。
The present invention will be described in more detail with reference to the following examples, but the present invention is not limited thereto.

【0019】実施例1 前述のメソッズ イン エンザイモロジー記載の方法で
SfiIの酵素標品を得た。次に、20mM トリス−
塩酸 pH7.5、10mM 2−メルカプトエタノー
ル、0.025%(v/v) トリトンX−100、及
び2単位/μlSfiIからなる酵素組成物を調製し、
該酵素組成物に下記表2に示す各物質を添加し、5℃で
3週間保存した後の活性を比較した。
Example 1 An enzyme preparation of SfiI was obtained by the method described in the method of enzymology described above. Next, 20 mM Tris-
An enzyme composition comprising hydrochloric acid pH 7.5, 10 mM 2-mercaptoethanol, 0.025% (v / v) Triton X-100, and 2 units / μl SfiI was prepared,
The substances shown in Table 2 below were added to the enzyme composition, and the activity after storage at 5 ° C. for 3 weeks was compared.

【0020】[0020]

【表2】 表 2 サンプル番号 添 加 物 最終添加濃度 1 なし − 2 EDTA 1mM 3 CaCl2 10mM 4 Ca(NO3 2 10mM 5 Ca(CH3 COO)2 10mM 6 MgCl2 10mM 7 MgSO4 10mM 8 Mg(CH3 COO)2 10mM 9 Mg(NO3 2 10mM 10 MnCl2 10mM 11 CoCl2 10mM 12 ZnCl2 10mM 13 CuCl2 10mM 14 NiCl2 10mM[Table 2] Table 2 Sample No. Additive Additive final concentration 1 None −2 EDTA 1 mM 3 CaCl 2 10 mM 4 Ca (NO 3 ) 2 10 mM 5 Ca (CH 3 COO) 2 10 mM 6 MgCl 2 10 mM 7 MgSO 4 10 mM 8 Mg (CH 3 COO) 2 10 mM 9 Mg (NO 3 ) 2 10 mM 10 MnCl 2 10 mM 11 CoCl 2 10 mM 12 ZnCl 2 10 mM 13 CuCl 2 10 mM 14 NiCl 2 10 mM

【0021】活性の比較はアデノウイルスDNAのPm
aCI消化断片(7563bp)をpUC18のHin
cII部位に挿入しXbaIで一箇所切断した基質DNA
と酵素組成物を前述の活性測定用緩衝液50μl中で5
0℃で1時間反応させて、基質DNAの切断の程度をア
ガロースゲル電気泳動にて比較することにより行った。
A comparison of the activity is made with the Pm of adenovirus DNA.
The aCI digested fragment (7563 bp) was ligated to Hin of pUC18.
Substrate DNA inserted into the cII site and cut at one site with XbaI
And the enzyme composition in 5 μl of the above-mentioned buffer for activity measurement.
The reaction was carried out at 0 ° C. for 1 hour, and the degree of cleavage of the substrate DNA was compared by agarose gel electrophoresis.

【0022】その結果、CaCl2 、Ca(N
3 2 、Ca(CH3 COO)2 を添加したサンプル
(サンプル番号3、4、5)は、酵素は安定に活性を保
持し、基質DNAを完全に切断した。一方、EDTA
(サンプル番号2)、各種マグネシウム塩(サンプル番
号6、7、8、9)、他の金属塩(サンプル番号10、
11、12、13、14)を添加したサンプル及び未添
加(サンプル番号1)のサンプルは酵素が失活し、基質
DNAを切断しなかった。
As a result, CaCl 2 , Ca (N
In the samples (Sample Nos. 3, 4, and 5) to which O 3 ) 2 and Ca (CH 3 COO) 2 were added, the enzyme stably retained the activity and the substrate DNA was completely cleaved. On the other hand, EDTA
(Sample No. 2), various magnesium salts (Sample Nos. 6, 7, 8, 9), other metal salts (Sample No. 10,
The enzyme was inactivated and the substrate DNA was not cleaved in the sample added with 11, 12, 13, 14) and the sample not added (Sample No. 1).

【0023】実施例2 50mM トリス−塩酸 pH7.5、10mM 2−
メルカプトエタノール、2単位/μlのSdiIからな
る酵素組成物にMgCl2 又はCaCl2 を終濃度10
mMとなるように添加し、5℃で4日間放置し、実施例
1と同様にして酵素活性を比較した。その結果、CaC
2 を添加したサンプルは、安定に活性を保持し基質D
NAを完全に切断した。一方、MgCl2 を添加したサ
ンプルは、活性の低下がみられ基質DNAの切断は不完
全であった。未添加のサンプルは酵素が失活し基質DN
Aを切断しなかった。
Example 2 50 mM Tris-hydrochloric acid pH 7.5, 10 mM 2-
A final concentration of MgCl 2 or CaCl 2 of 10 was added to an enzyme composition consisting of mercaptoethanol and 2 units / μl of SdiI.
The enzyme activity was compared in the same manner as in Example 1 after the addition of mM so that the mixture was allowed to stand at 5 ° C. for 4 days. As a result, CaC
The sample to which l 2 was added stably retained the activity and the substrate D
NA was completely cut. On the other hand, in the sample to which MgCl 2 was added, the activity was decreased and the cleavage of the substrate DNA was incomplete. In the sample without addition, the enzyme is inactivated and the substrate DN
A was not cut.

【0024】実施例3 下記表3に示す組成からなる安定化された酵素組成物を
調製した。
Example 3 A stabilized enzyme composition having the composition shown in Table 3 below was prepared.

【0025】[0025]

【表3】 表 3 30単位/μl SfiI 10mM トリス−塩酸 pH7.5 1mM DTT 0.1mM EDTA 200mM KCl 10mM CaCl2 0.15%(v/v) トリトンX−100 50%(v/v) グリセロール この酵素組成物は−20℃で少なくとも3ヵ月間安定で
あった。
Table 3 30 Units / μl SfiI 10 mM Tris-hydrochloric acid pH 7.5 1 mM DTT 0.1 mM EDTA 200 mM KCl 10 mM CaCl 2 0.15% (v / v) Triton X-100 50% (v / v) Glycerol The enzyme composition was stable at -20 ° C for at least 3 months.

【0026】[0026]

【発明の効果】本発明により、遺伝子工学用試薬として
有用な制限酵素の長期安定化に有用な安定化剤を含有す
る制限酵素組成物が提供された。
INDUSTRIAL APPLICABILITY The present invention provides a restriction enzyme composition containing a stabilizer useful for long-term stabilization of a restriction enzyme useful as a reagent for genetic engineering.

【0027】[0027]

【配列表】[Sequence list]

【0028】配列番号:1 配列の長さ:13 配列の型:核酸 鎖の数:二本鎖 配列の特徴:5〜9番目のNは任意のヌクレオシドであ
る。 配列: GGCCNNNNNG GCC 13
SEQ ID NO: 1 Sequence length: 13 Sequence type: Nucleic acid Number of strands: Double-stranded Sequence features: N at the 5th to 9th positions are arbitrary nucleosides. Sequence: GGCCNNNNNG GCC 13

【0029】配列番号:2 配列の長さ:13 配列の型:核酸 鎖の数:二本鎖 配列の特徴:3番目のCは m5cである。 5〜9番目のNは任意のヌクレオシドである。 12番目のCは m5cである。 配列: GGCCNNNNNG GCC 13SEQ ID NO: 2 Sequence length: 13 Sequence type: Nucleic acid Number of strands: Double stranded Sequence characteristics: C at the 3rd position is m5c. The 5th to 9th Ns are arbitrary nucleosides. The 12th C is m5c. Sequence: GGCCNNNNNG GCC 13

───────────────────────────────────────────────────── フロントページの続き (72)発明者 君塚 房夫 滋賀県大津市瀬田3丁目4番1号 寳酒造 株式会社中央研究所内 (72)発明者 中島 和男 滋賀県大津市瀬田3丁目4番1号 寳酒造 株式会社中央研究所内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Fusao Kimizuka 3-4-1 Seta, Otsu City, Shiga Prefecture Central Research Institute, Minami Shuzo Co., Ltd. (72) Inventor Kazuo Nakajima 3-4-1 Seta, Otsu City, Shiga Prefecture No. Sake Brewing Co., Ltd. Central Research Institute

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 制限酵素の組成物であって、カルシウム
塩を含有することを特徴とする安定化された酵素組成
物。
1. A stabilized enzyme composition comprising a restriction enzyme, which contains a calcium salt.
【請求項2】 制限酵素が二本鎖DNAの下記式(化
1) 【化1】 (式中、Gはグアノシン、Cはシチジン、Nは任意のヌ
クレオシドを表す)で表される塩基配列を特異的に認識
し、かつ矢印の部位で特異的に切断する能力を有する制
限酵素である請求項1記載の酵素組成物。
2. The following formula (Formula 1) wherein the restriction enzyme is double-stranded DNA: (Wherein G represents guanosine, C represents cytidine, and N represents any nucleoside), which is a restriction enzyme capable of specifically recognizing the base sequence and having the ability to specifically cleave at the site indicated by the arrow. The enzyme composition according to claim 1.
JP15819693A 1993-06-04 1993-06-04 Enzyme composition Expired - Fee Related JP3184009B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP15819693A JP3184009B2 (en) 1993-06-04 1993-06-04 Enzyme composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP15819693A JP3184009B2 (en) 1993-06-04 1993-06-04 Enzyme composition

Publications (2)

Publication Number Publication Date
JPH06343468A true JPH06343468A (en) 1994-12-20
JP3184009B2 JP3184009B2 (en) 2001-07-09

Family

ID=15666377

Family Applications (1)

Application Number Title Priority Date Filing Date
JP15819693A Expired - Fee Related JP3184009B2 (en) 1993-06-04 1993-06-04 Enzyme composition

Country Status (1)

Country Link
JP (1) JP3184009B2 (en)

Also Published As

Publication number Publication date
JP3184009B2 (en) 2001-07-09

Similar Documents

Publication Publication Date Title
Coburn et al. Reconstitution of the degradation of the mRNA for ribosomal protein S20 with purified enzymes
Nasheuer et al. Immunoaffinity-purified DNA polymerase. alpha. displays novel properties
JP2010528669A (en) Polymerase stabilization
JP2003525601A (en) Methods of reverse transcription using Bacillus-stearothermophilus or Thermoactinomyces-bulgaris DNA polymerase
Tanaka et al. Mutational and proteolytic studies on a flexible loop in glutathione synthetase from Escherichia coli B: the loop and arginine 233 are critical for the catalytic reaction
Cudny et al. Escherichia coli RNase D. Catalytic properties and substrate specificity.
Shashi et al. ATP: citrate lyase of Rhodotorula gracilis: purification and properties
JPH06343468A (en) Enzyme composition
Deutscher Transfer RNA nucleotidyltransferase
EP0009781B1 (en) Process for the purification of long-chain acyl-coenzyme-a synthetase and the enzyme, acyl-coa synthetase, purified thereby
David et al. Cloning, expression, and purification of rat brain protein L-isoaspartyl methyltransferase
Bergmann [96] Bacterial amino acyl RNA synthetases
Yamamoto et al. Purification and characterization of yeast UDP-N-acetylglucosamine pyrophosphorylase
JP2624217B2 (en) Lactate oxidase and lactate oxidase gene
US5120651A (en) Restriction enzyme agei and process for producing same
Legrain et al. [20] Ornithine carbamoyltransferase from Pyrococcus furfosus
JP3803295B2 (en) Stable composition containing nuclease and phosphatase
JPH0423987A (en) Stabilized restriction enzyme sfil composition
Helfman et al. Escherichia coli DNA polymerases II and III: activation by magnesium or by manganous ions
JP2007097517A (en) Sugar phosphorylation agent and sugar phosphorylation method
JP2008109874A (en) Enzyme composition for self-cyclizatin of dna
DK145700B (en) ENDONUCLEASES AND PROCEDURES FOR PREPARING IT
US7416871B2 (en) Thermo-stable lactate oxidase
JPH07163341A (en) Stabilized and modified protein
Jones et al. Human Class 1 Aldehyde Dehydrogenase: Expression and Site-Directed Mutagenesis

Legal Events

Date Code Title Description
LAPS Cancellation because of no payment of annual fees